NCT01629498View on ClinicalTrials.gov

Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 17, 2012

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Recurrent Lung Non-Small Cell CarcinomaStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Interventions
RADIATION

Image Guided Radiation Therapy

Undergo image-guided IMRT

RADIATION

Image Guided Radiation Therapy

Undergo image-guided IMPT

RADIATION

Intensity-Modulated Radiation Therapy

Undergo image-guided IMRT

RADIATION

Intensity-Modulated Radiation Therapy

Undergo image-guided IMPT

OTHER

Laboratory Biomarker Analysis

Optional correlative studies

RADIATION

Photon Beam Radiation Therapy

Undergo image-guided IMRT

RADIATION

Proton Beam Radiation Therapy

Undergo image-guided IMPT

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01629498 - Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter